Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21471106 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients
Condition: Cystic Fibrosis (CF)
Interventions: Drug: MP-376;   Drug: Placebo

Indicates status has not been verified in more than two years